DRUG-DRUG INTERACTION OF BUPROPION WITH ELAGOLIX, A NOVEL ORAL GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTOR ANTAGONIST.

被引：0

作者：

Polepally, A. ^{[1
]}

Dharia, S. ^{[2
]}

Shebley, M. ^{[3
]}

Mostafa, N. ^{[3
]}

Ali, F. ^{[3
]}

机构：

[1] AbbVie Biotherapeut, Redwood City, CA USA

[2] AbbVie, Mettawa, IL USA

[3] AbbVie, N Chicago, IL USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PII-113

引用

页码：S66 / S66

页数：1

共 50 条

[31] KINETICS OF BINDING OF GONADOTROPIN-RELEASING HORMONE (GNRH) AND PURIFIED GNRH RECEPTOR PROTEIN (GNRH R)
ZOLMAN, JC
VALENTA, LJ
CLINICAL RESEARCH, 1977, 25 (02): : A108 - A108
[32] REGULATION VERSUS MODULATION IN THE GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTOR FUNCTION
ZOLMAN, JC
THEODOROPOULOS, TJ
CLINICAL RESEARCH, 1983, 31 (05): : A835 - A835
[33] MOLECULAR MECHANISM OF GONADOTROPIN-RELEASING HORMONE (GNRH) ACTION .1. THE GNRH RECEPTOR
HAZUM, E
CONN, PM
ENDOCRINE REVIEWS, 1988, 9 (04) : 379 - 386
[34] Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor
Kraus, S
Naor, Z
Seger, R
ARCHIVES OF MEDICAL RESEARCH, 2001, 32 (06) : 499 - 509
[35] Relugolix: A Novel Gonadotropin-Releasing Hormone Antagonist for Prostate Cancer
Babu, Merin
Pavithran, Keechilat
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2021, 12 (01) : 26 - 28
[36] Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of-the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix - Editorial comment
Jaffe, Robert B.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (06) : 386 - 388
[37] LUTEINIZING-HORMONE RELEASE AND GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTOR INTERNALIZATION - INDEPENDENT ACTIONS OF GNRH
CONN, PM
HAZUM, E
ENDOCRINOLOGY, 1981, 109 (06) : 2040 - 2045
[38] The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist
Taylor, Joelle E.
Miller, Bradley T.
Gray, Karen D.
Scott, Richard T., Jr.
Catherino, William H.
Segars, James H.
FERTILITY AND STERILITY, 2010, 93 (05) : 1668 - 1675
[39] Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer
George, Daniel J.
Dearnaley, David P.
FUTURE ONCOLOGY, 2021, 17 (33) : 4431 - 4446
[40] Monoclonal antibodies to gonadotropin-releasing hormone (GnRH) inhibit binding of the hormone to its receptor
Gangatirkar, P
Gangadharan, S
Narendranath, A
Nagpal, S
Salunke, DM
Karande, AA
HYBRIDOMA AND HYBRIDOMICS, 2002, 21 (04): : 281 - 286

← 1 2 3 4 5 →